company background image
SCIE

Scientex Berhad KLSE:SCIENTX Stock Report

Last Price

RM3.47

Market Cap

RM5.4b

7D

-3.3%

1Y

-18.0%

Updated

25 Jun, 2022

Data

Company Financials +
SCIENTX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends4/6

SCIENTX Stock Overview

Scientex Berhad, an investment holding company, manufactures and sells various packaging products.

Scientex Berhad Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Scientex Berhad
Historical stock prices
Current Share PriceRM3.47
52 Week HighRM5.00
52 Week LowRM3.37
Beta0.54
1 Month Change-0.86%
3 Month Change-14.32%
1 Year Change-17.97%
3 Year Change20.49%
5 Year Change18.30%
Change since IPO3,007.54%

Recent News & Updates

Apr 28
Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting Stock

Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting Stock

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Shareholder Returns

SCIENTXMY ChemicalsMY Market
7D-3.3%-2.6%-1.2%
1Y-18.0%9.3%-8.7%

Return vs Industry: SCIENTX underperformed the MY Chemicals industry which returned 9.3% over the past year.

Return vs Market: SCIENTX underperformed the MY Market which returned -8.7% over the past year.

Price Volatility

Is SCIENTX's price volatile compared to industry and market?
SCIENTX volatility
SCIENTX Average Weekly Movement3.2%
Chemicals Industry Average Movement5.0%
Market Average Movement5.5%
10% most volatile stocks in MY Market11.4%
10% least volatile stocks in MY Market2.9%

Stable Share Price: SCIENTX is less volatile than 75% of MY stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: SCIENTX's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19683,600Peng Jin Limhttps://www.scientex.com.my

Scientex Berhad, an investment holding company, manufactures and sells various packaging products. It operates in two segments, Packaging and Property Development. The company offers various packaging products, such as stretch films, polypropylene (PP) strapping bands, FIBC bags, HDPE and PP tying tapes, and form-fill and seal bags.

Scientex Berhad Fundamentals Summary

How do Scientex Berhad's earnings and revenue compare to its market cap?
SCIENTX fundamental statistics
Market CapRM5.38b
Earnings (TTM)RM427.54m
Revenue (TTM)RM3.84b

12.6x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SCIENTX income statement (TTM)
RevenueRM3.84b
Cost of RevenueRM2.81b
Gross ProfitRM1.03b
Other ExpensesRM604.27m
EarningsRM427.54m

Last Reported Earnings

Apr 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.28
Gross Margin26.84%
Net Profit Margin11.12%
Debt/Equity Ratio40.2%

How did SCIENTX perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

33%

Payout Ratio

Does SCIENTX pay a reliable dividends?

See SCIENTX dividend history and benchmarks
When do you need to buy SCIENTX by to receive an upcoming dividend?
Scientex Berhad dividend dates
Ex Dividend DateJul 07 2022
Dividend Pay DateJul 22 2022
Days until Ex dividend11 days
Days until Dividend pay date26 days

Does SCIENTX pay a reliable dividends?

See SCIENTX dividend history and benchmarks
We’ve recently updated our valuation analysis.

Valuation

Is SCIENTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SCIENTX?

Other financial metrics that can be useful for relative valuation.

SCIENTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.8x
Enterprise Value/EBITDA10.3x
PEG Ratio0.7x

Price to Earnings Ratio vs Peers

How does SCIENTX's PE Ratio compare to its peers?

SCIENTX PE Ratio vs Peers
The above table shows the PE ratio for SCIENTX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average6.9x

Price-To-Earnings vs Peers: SCIENTX is expensive based on its Price-To-Earnings Ratio (12.6x) compared to the peer average (6.9x).


Price to Earnings Ratio vs Industry

How does SCIENTX's PE Ratio compare vs other companies in the Chemicals Industry?

Price-To-Earnings vs Industry: SCIENTX is expensive based on its Price-To-Earnings Ratio (12.6x) compared to the MY Chemicals industry average (12.6x)


Price to Earnings Ratio vs Fair Ratio

What is SCIENTX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SCIENTX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.6x
Fair PE Ratio20.6x

Price-To-Earnings vs Fair Ratio: SCIENTX is good value based on its Price-To-Earnings Ratio (12.6x) compared to the estimated Fair Price-To-Earnings Ratio (20.6x).


Share Price vs Fair Value

What is the Fair Price of SCIENTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SCIENTX (MYR3.47) is trading below our estimate of fair value (MYR6.69)

Significantly Below Fair Value: SCIENTX is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: SCIENTX is good value based on its PEG Ratio (0.7x)


Discover undervalued companies

Future Growth

How is Scientex Berhad forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


18.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SCIENTX's forecast earnings growth (18% per year) is above the savings rate (3.6%).

Earnings vs Market: SCIENTX's earnings (18% per year) are forecast to grow faster than the MY market (9.9% per year).

High Growth Earnings: SCIENTX's earnings are forecast to grow, but not significantly.

Revenue vs Market: SCIENTX's revenue (11.8% per year) is forecast to grow faster than the MY market (5.2% per year).

High Growth Revenue: SCIENTX's revenue (11.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SCIENTX's Return on Equity is forecast to be low in 3 years time (15.9%).


Discover growth companies

Past Performance

How has Scientex Berhad performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


13.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SCIENTX has high quality earnings.

Growing Profit Margin: SCIENTX's current net profit margins (11.1%) are lower than last year (12.5%).


Past Earnings Growth Analysis

Earnings Trend: SCIENTX's earnings have grown by 13.8% per year over the past 5 years.

Accelerating Growth: SCIENTX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SCIENTX had negative earnings growth (-6.4%) over the past year, making it difficult to compare to the Chemicals industry average (15.6%).


Return on Equity

High ROE: SCIENTX's Return on Equity (14%) is considered low.


Discover strong past performing companies

Financial Health

How is Scientex Berhad's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SCIENTX's short term assets (MYR1.9B) exceed its short term liabilities (MYR1.8B).

Long Term Liabilities: SCIENTX's short term assets (MYR1.9B) exceed its long term liabilities (MYR431.9M).


Debt to Equity History and Analysis

Debt Level: SCIENTX's net debt to equity ratio (36.6%) is considered satisfactory.

Reducing Debt: SCIENTX's debt to equity ratio has reduced from 43.4% to 40.2% over the past 5 years.

Debt Coverage: SCIENTX's debt is well covered by operating cash flow (53.4%).

Interest Coverage: SCIENTX's interest payments on its debt are well covered by EBIT (26.2x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Scientex Berhad current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.59%

Current Dividend Yield

Upcoming Dividend Payment

TodayJun 26 2022Ex Dividend DateJul 07 2022Dividend Pay DateJul 22 202215 days from Ex DividendBuy in the next 11 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: SCIENTX's dividend (2.59%) is higher than the bottom 25% of dividend payers in the MY market (2.15%).

High Dividend: SCIENTX's dividend (2.59%) is low compared to the top 25% of dividend payers in the MY market (4.91%).


Stability and Growth of Payments

Stable Dividend: SCIENTX's dividend payments have been volatile in the past 10 years.

Growing Dividend: SCIENTX's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (32.6%), SCIENTX's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (27.9%), SCIENTX's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

14.4yrs

Average management tenure


CEO

Peng Jin Lim (54 yo)

20.58yrs

Tenure

RM120,000

Compensation

Mr. Peng Jin Lim has been the Managing Director of Scientex Packaging Berhad (formerly Woventex Corporation Berhad) since October 18, 2001. Mr. Lim has been the Managing Director of Scientex Berhad since N...


CEO Compensation Analysis

Compensation vs Market: Peng Jin's total compensation ($USD27.28K) is below average for companies of similar size in the MY market ($USD501.94K).

Compensation vs Earnings: Peng Jin's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SCIENTX's management team is seasoned and experienced (14.4 years average tenure).


Board Members

Experienced Board: SCIENTX's board of directors are seasoned and experienced ( 13.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Scientex Berhad's employee growth, exchange listings and data sources


Key Information

  • Name: Scientex Berhad
  • Ticker: SCIENTX
  • Exchange: KLSE
  • Founded: 1968
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Implied Market Cap: RM5.382b
  • Shares outstanding: 1.55b
  • Website: https://www.scientex.com.my

Number of Employees


Location

  • Scientex Berhad
  • No. 9, Persiaran Selangor
  • Seksyen 15
  • Shah Alam
  • Selangor
  • 40200
  • Malaysia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/25 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/04/30
Annual Earnings2021/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.